Abstract
The penetration of intravenously administered cefuroxime into ventricular fluid was assessed in five pediatric patients with ventriculoperitoneal shunt infections and in one with a ventriculostomy infection. Patients received a total dose of 200 to 230 mg of cefuroxime per kg of body weight per day administered at 8-h intervals. Levels of cefuroxime in ventricular fluid ranged from 1.6 to 22.5 micrograms/ml and were associated with cerebrospinal fluid bactericidal titers ranging from less than 1:2 to 1:16 against infecting staphylococcal isolates. Five infections were cured with cefuroxime monotherapy. On the basis of MIC data, one patient had vancomycin substituted for cefuroxime and the infection was cured.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
- Bennett J. V., Brodie J. L., Benner E. J., Kirby W. M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 1966 Mar;14(2):170–177. doi: 10.1128/am.14.2.170-177.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Creger R. J., Cowan R. I., Nearman H. S., Blumer J. L., Selman W. R., Danziger L. H. Cerebrospinal fluid penetration of moxalactam in ventriculostomy patients. Antimicrob Agents Chemother. 1985 Dec;28(6):839–841. doi: 10.1128/aac.28.6.839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Forward K. R., Fewer H. D., Stiver H. G. Cerebrospinal fluid shunt infections. A review of 35 infections in 32 patients. J Neurosurg. 1983 Sep;59(3):389–394. doi: 10.3171/jns.1983.59.3.0389. [DOI] [PubMed] [Google Scholar]
- Johnston R. B., Jr The host response to invasion by Streptococcus pneumoniae: protection and the pathogenesis to tissue damage. Rev Infect Dis. 1981 Mar-Apr;3(2):282–288. doi: 10.1093/clinids/3.2.282. [DOI] [PubMed] [Google Scholar]
- Lennon D., Lewis B., Mantell C., Becroft D., Dove B., Farmer K., Tonkin S., Yeates N., Stamp R., Mickleson K. Epidemic perinatal listeriosis. Pediatr Infect Dis. 1984 Jan-Feb;3(1):30–34. doi: 10.1097/00006454-198401000-00008. [DOI] [PubMed] [Google Scholar]
- Müller C., Netland A., Dawson A. F., Andrew E. The penetration of cefuroxime into the cerebrospinal fluid through inflamed and non-inflamed meninges. J Antimicrob Chemother. 1980 Mar;6(2):279–283. doi: 10.1093/jac/6.2.279. [DOI] [PubMed] [Google Scholar]
- Odio C., McCracken G. H., Jr, Nelson J. D. CSF shunt infections in pediatrics. A seven-year experience. Am J Dis Child. 1984 Dec;138(12):1103–1108. doi: 10.1001/archpedi.1984.02140500009004. [DOI] [PubMed] [Google Scholar]
- Pfenninger J., Schaad U. B., Lütschg J., Nussbaumer A., Zellweger U. Cefuroxime in bacterial meningitis. Arch Dis Child. 1982 Jul;57(7):539–543. doi: 10.1136/adc.57.7.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sirinavin S., Chiemchanya S., Visudhipan P., Lolekha S. Cefuroxime treatment of bacterial meningitis in infants and children. Antimicrob Agents Chemother. 1984 Feb;25(2):273–275. doi: 10.1128/aac.25.2.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yogev R. Cerebrospinal fluid shunt infections: a personal view. Pediatr Infect Dis. 1985 Mar-Apr;4(2):113–118. doi: 10.1097/00006454-198503000-00001. [DOI] [PubMed] [Google Scholar]
- del Rio M. de los A., Chrane D. F., Shelton S., McCracken G. H., Jr, Nelson J. D. Pharmacokinetics of cefuroxime in infants and children with bacterial meningitis. Antimicrob Agents Chemother. 1982 Dec;22(6):990–994. doi: 10.1128/aac.22.6.990. [DOI] [PMC free article] [PubMed] [Google Scholar]
